A comparison of toxicity following two different doses of cyclophosphamide for mobilization of peripheral blood progenitor cells in 116 multiple myeloma patients
- 1 April 2001
- journal article
- clinical trial
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 27 (8) , 837-842
- https://doi.org/10.1038/sj.bmt.1702879
Abstract
Bone Marrow Transplantation is a high quality, peer-reviewed journal covering all aspects of clinical and basic haemopoietic stem cell transplantation.Keywords
This publication has 19 references indexed in Scilit:
- A Prospective, Randomized Trial of Autologous Bone Marrow Transplantation and Chemotherapy in Multiple MyelomaNew England Journal of Medicine, 1996
- Peripheral blood progenitor cell collections in multiple myeloma: predictors and management of inadequate collectionsBritish Journal of Haematology, 1996
- Comparative study of peripheral blood progenitor cell collection in patients with multiple myeloma after single‐dose cyclophosphamide combined with rhGM‐CSF or rhG‐CSFBritish Journal of Haematology, 1995
- A comparison of peripheral blood stem cell mobilisation after chemotherapy with cyclophosphamide as a single agent in doses of 4 g/m2 or 7 g/m2 in patients with advanced cancerAustralian and New Zealand Journal of Medicine, 1992
- Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapyThe Lancet, 1992
- Maintenance Treatment with Recombinant Interferon Alfa-2b in Patients with Multiple Myeloma Responding to Conventional Induction ChemotherapyNew England Journal of Medicine, 1990
- GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR TO HARVEST CIRCULATING HAEMOPOIETIC STEM CELLS FOR AUTOTRANSPLANTATIONThe Lancet, 1989
- Effective Treatment of Advanced Multiple Myeloma Refractory to Alkylating AgentsNew England Journal of Medicine, 1984
- Reporting results of cancer treatmentCancer, 1981
- Combination chemotherapy for multiple myelomaCancer, 1972